This invention describes contact lenses designed to deliver medication directly to the eye. The lenses have a special coating applied using printing technology, like an inkjet printer. This coating contains an emulsion that stores hydrophobic drugs, such as prostaglandins, and helps release them while also keeping them stable.
Why it matters: Given the patent was filed very recently in 2024, the core challenges of precisely printing stable drug-laden emulsions onto biocompatible contact lenses likely remain similar. Significant advancements in this highly specialized field are unlikely to have emerged and matured in just two years.
AI gives you a few directions you could take this. Pick one, and we check whether your version is different enough to patent, then write the filing.
Reinvent this with AI